Clinical trial for Radiologically Isolated Syndromes; Multiple Sclerosis
Official title Comparison of Digital Biomarkers in Subjects With Radiologically Isolated Syndrome (RIS) and Multiple Sclerosis (MS) Patients With Clinically Normal Neurological Examination
ClinicalTrials.gov ID: NCT07135752
What this study is testing
- What it's testing
- The study wants to see if these biomarkers are similar in RIS and early‑stage MS and whether they can predict disease progression.
- Who it's for
- Adults diagnosed with radiologically isolated syndrome or multiple sclerosis who have a completely normal neurological exam.
- What's involved
- Participants will complete digital assessments, undergo MRI scans, and provide blood or spinal‑fluid samples for biomarker testing.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60
You may be able to join if
- Patients fulfilling the 2023 diagnostic RIS criteria
- Patients with a radiologically isolated syndrome (RIS) identified in local OFSEP databases (French Multiple Sclerosis Observatory) MS patients: \-...
You likely can't join if
- The presence of motor, visual or cognitive deficits unrelated to MS that may interfere with test performance
- A diagnosis of progressive MS
The study team makes the final eligibility decision.
Where it is enrolling
- Nice, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Nice, France. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.